The team behind Russia’s pioneering coronavirus jab has claimed that EU members are already working to ensure they are first in line to manufacture dozes, even though a review by the bloc’s central regulator has not yet finished.
The European Medicines Agency (EMA) announced at the beginning of March that its officials were studying the results of clinical trials using the formula before Sputnik got the green light for use across the bloc. However, the regulator’s head of vaccine strategy, Marco Cavaleri, told Italian news station Radio24 that the process would not be a swift one. “In the coming weeks we will see if we can approve the vaccine,” he said. “But until the end of April we will not be ready to approve Sputnik V, but rather in May.”
Continue reading https://on.rt.com/b3sz